Center-Authored Papers

Filters: Author is Olson, James M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Xenograft Model Antitumor Assays
Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson JM, Zhang M.  2008.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.. Nanomedicine (London, England). 3(4):495-505. Abstract
Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA.  2011.  Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.. BMC cancer. 11:144. Abstract
Vaccine and Infectious Disease Division
Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P et al..  2013.  Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.. Genes & development. 27(9):1032-45. Abstract
Tumor Markers, Biological
Wu C, Hansen SJ, Hou Q, Yu J, Zeigler M, Jin Y, Burnham DR, McNeill JD, Olson JM, Chiu DT.  2011.  Design of highly emissive polymer dot bioconjugates for in vivo tumor targeting.. Angewandte Chemie (International ed. in English). 50(15):3430-4.
tubulin
Lee SJ, Krauthauser C, Maduskuie V, Fawcett PT, Olson JM, Rajasekaran SA.  2011.  Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.. BMC cancer. 11:144. Abstract
Trinucleotide Repeat Expansion
Benn CL, Luthi-Carter R, Kuhn A, Sadri-Vakili G, Blankson KL, Dalai SC, Goldstein DR, Spires TL, Pritchard J, Olson JM et al..  2010.  Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease.. Journal of neuropathology and experimental neurology. 69(8):817-27. Abstract
Translocation, Genetic
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Translational Bioimaging Center Core Facility
Sun C, Veiseh O, Gunn J, Fang C, Hansen S, Lee D, Sze R, Ellenbogen RG, Olson JM, Zhang M.  2008.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.. Small (Weinheim an der Bergstrasse, Germany). 4(3):372-9. Abstract
Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG et al..  2009.  Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.. Cancer research. 69(15):6200-7. Abstract
Lee MJ-E, Veiseh O, Bhattarai N, Sun C, Hansen SJ, Ditzler S, Knoblaugh SE, Lee D, Ellenbogen R, Zhang M et al..  2010.  Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method.. PloS one. 5(3):e9536. Abstract
Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee D, Ellenbogen RG, Olson JM, Zhang M.  2009.  PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection.. Advanced functional materials. 19(14):2244-2251. Abstract
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
Sun C, Fang C, Stephen Z, Veiseh O, Hansen S, Lee D, Ellenbogen RG, Olson JM, Zhang M.  2008.  Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.. Nanomedicine (London, England). 3(4):495-505. Abstract
Transgenes
Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG et al..  2008.  The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.. Cancer research. 68(6):1768-76. Abstract
Transforming Growth Factor beta
Spiller SE, Ditzler SH, Pullar BJ, Olson JM.  2008.  Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).. Journal of neuro-oncology. 87(2):133-41. Abstract
Northcott PA, Shih DJH, Peacock J, Garzia L, Morrissy SA, Zichner T, Stütz AM, Korshunov A, Reimand J, Schumacher SE et al..  2012.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes.. Nature. 488(7409):49-56. Abstract
Transfection
Ravanpay AC, Olson JM.  2008.  E protein dosage influences brain development more than family member identity.. Journal of neuroscience research. 86(7):1472-81. Abstract
TRANSCRIPTIONAL ACTIVATION
Ravanpay AC, Hansen SJ, Olson JM.  2010.  Transcriptional inhibition of REST by NeuroD2 during neuronal differentiation.. Molecular and cellular neurosciences. 44(2):178-89. Abstract
Transcription, Genetic
Spiller SE, Ditzler SH, Pullar BJ, Olson JM.  2008.  Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).. Journal of neuro-oncology. 87(2):133-41. Abstract
TRANSCRIPTION FACTORS
Cho Y-J, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, Berhoukim R, Amani V, Goumnerova L, Eberhart CG et al..  2011.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(11):1424-30. Abstract
Ravanpay AC, Hansen SJ, Olson JM.  2010.  Transcriptional inhibition of REST by NeuroD2 during neuronal differentiation.. Molecular and cellular neurosciences. 44(2):178-89. Abstract
Pritchard JI, Olson JM.  2008.  Methylation of PTCH1, the Patched-1 gene, in a panel of primary medulloblastomas.. Cancer genetics and cytogenetics. 180(1):47-50. Abstract
TISSUE DISTRIBUTION
Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG et al..  2009.  Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.. Cancer research. 69(15):6200-7. Abstract
Lee MJ-E, Veiseh O, Bhattarai N, Sun C, Hansen SJ, Ditzler S, Knoblaugh SE, Lee D, Ellenbogen R, Zhang M et al..  2010.  Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method.. PloS one. 5(3):e9536. Abstract
Time Factors
Lee MJ-E, Veiseh O, Bhattarai N, Sun C, Hansen SJ, Ditzler S, Knoblaugh SE, Lee D, Ellenbogen R, Zhang M et al..  2010.  Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method.. PloS one. 5(3):e9536. Abstract